Medical News

RSS

EGS announced that enrollment for RESPECT study has surpassed company's original target

EndoGastric Solutions (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced today that enrollment for the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial) is complete and has surpassed the company's original target of 120 patients.

9 Oct 2013

Report: States lax in taking steps to curb prescription drug abuse

The number of deaths attributed to the abuse of painkillers and other prescription drugs has risen sharply in recent years.

9 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

9 Oct 2013

Saint Luke's Health System launches doxo to enhance quality of services

Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.

9 Oct 2013

Francisco Partners invests in NexTech

Francisco Partners, a leading technology-focused private equity firm, today announced a strategic investment in NexTech, a leading provider of fully integrated electronic medical records, practice management, and marketing software solutions for specialty physician practices. Closing is subject to customary conditions, including Hart-Scott-Rodino clearance.

9 Oct 2013

Ramsell partners with Alameda County to provide pharmacy benefits management services

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management services to more than 900 low-income mental health patients.

9 Oct 2013

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in the pivotal, multinational phase 3 study evaluating aripiprazole lauroxil in patients with schizophrenia.

9 Oct 2013

Despite sales efforts, polls show continued Obamacare doubts

Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups -- among them, physician practices and likely Virginia voters -- show continued doubts about the marketplaces.

9 Oct 2013

Laborie acquires UroMed's pelvic muscle rehabilitation business

Laborie Medical Technologies, Inc., a portfolio company of Audax Group, announced it has completed the acquisition of UroMed Technology, Inc.'s pelvic muscle rehabilitation business.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Moximed, Inc. announced today that the KineSpring® System, an implantable medical spring for knee osteoarthritis that works by unloading the weight on the diseased joint, has been successfully implanted in the first patients enrolled in the UK arm of its multi-centre GOAL study.

9 Oct 2013

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

Bariatric Advantage today announced that bariatric patients now have another option to increase their daily protein intake with the new decaffeinated version of Pro Joe Magnifico Mocha.

9 Oct 2013

ReAttach therapy can be effective treatment for people with autism

"ReAttach" is a new intervention, based on "attachment". Practical research has pointed out that the "ReAttach therapy" can be of great importance for people with autism. This is concluded from the continuous practical research of Paula Bartholomeus into the advantages that can be reached for people with Asperger's syndrome, PDD-NOS, autism spectrum disorder, or with a mental disability and autism, using the ReAttach therapy.

9 Oct 2013

AdvantEdge Healthcare launches QualityEdge information capture service

AdvantEdge Healthcare Solutions, one of the nation's leading providers of medical billing, practice management, and coding services for specialty physicians, hospitals, and surgery centers, is launching its QualityEdgeSM information capture service, which allows physicians and other providers to easily capture data that would otherwise require paper notes or the use of an EMR.

9 Oct 2013

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Biomet, Inc. announced today financial results for its first quarter ended August 31, 2013.

9 Oct 2013

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.

9 Oct 2013

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.

9 Oct 2013

MRFBC launches clinical trial to assess impact of bevacizumab and vemurafenib in melanoma patients

The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.

8 Oct 2013

Medical News

EGS announced that enrollment for RESPECT study has surpassed company's original target

Report: States lax in taking steps to curb prescription drug abuse

Bayer HealthCare receives FDA approval for Adempas tablets

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Saint Luke's Health System launches doxo to enhance quality of services

Francisco Partners invests in NexTech

Ramsell partners with Alameda County to provide pharmacy benefits management services

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Despite sales efforts, polls show continued Obamacare doubts

Laborie acquires UroMed's pelvic muscle rehabilitation business

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

ReAttach therapy can be effective treatment for people with autism

AdvantEdge Healthcare launches QualityEdge information capture service

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

MRFBC launches clinical trial to assess impact of bevacizumab and vemurafenib in melanoma patients

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News